Chlamydia trachomatis modulates expression of tumor suppressor gene caveolin-1 and oncogene C-myc in the transformation zone of non-neoplastic cervical tissue

Gynecologic Oncology

Volumn 98, Issue 3, 2005, Pages 409-419

  Schlott, Thilo ^a   Eiffert, Helmut ^a   Bohne, Wolfgang ^a   Landgrebe, Jobst ^a   Brunner, Edgar ^a   Spielbauer, Bettina ^a   Knight, Bryan ^b  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b Dynacare Kasper Medical Laboratories   (Canada)

Author keywords

C. trachomatis; Cervix uteri; Microarray; Real time RT PCR

Indexed keywords

CAVEOLIN 1; MYC PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; CARCINOGENESIS; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; FIBROBLAST CULTURE; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; ONCOGENE C MYC; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; TUMOR SUPPRESSOR GENE; UTERINE CERVIX CANCER; UTERINE CERVIX EPITHELIUM;

CAVEOLIN 1; CAVEOLINS; CELL TRANSFORMATION, NEOPLASTIC; CERVIX UTERI; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; FEMALE; FIBROBLASTS; GENES, MYC; GENES, TUMOR SUPPRESSOR; HUMANS; INTERFERON TYPE II; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTO-ONCOGENE PROTEINS C-MYC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; UP-REGULATION; UTERINE CERVICAL NEOPLASMS;

EID: 23844448337     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2005.04.034     Document Type: Article

References (67)

1. R.M. Richards Cervical intraepithelial neoplasia Pathol. Annu. 8 1973 301 328
2. P.A. Lazo The molecular genetics of cervical carcinoma Br. J. Cancer 80 1999 2008 2018
3. J.H. Lee, S.K. Lee, M.H. Yang, M.M. Ahmed, M. Mohiuddin, and E.Y. Lee Expression and mutation of H-ras in uterine cervical cancer Gynecol. Oncol. 62 1996 49 54
4. J.J. O'Leary, R.J. Landers, M. Crowley, I. Healy, W.F. Kealy, and J. Hogan Alterations in exon 1 of c-myc and expression of p62c-myc in cervical squamous cell carcinoma J. Clin. Pathol. 50 1997 896 903
5. H. Furumoto, and M. Irahara Human papilloma virus (HPV) and cervical cancer J. Med. Invest. 49 2002 124 133
6. A. Sharma, M. Pratap, V.M. Sawhney, I.U. Khan, S. Bhambhani, and A.B. Mitra Frequent amplification of C-erbB2 (Her-2/Neu) oncogene in cervical carcinomas as detected by non-fluorescence in situ hybridization technique on paraffin sections Oncology 56 1999 83 87
7. A. Chatterjee, H.A. Pulido, S. Koul, N. Beleno, A. Perilla, and H. Posso Mapping the sites of putative tumor suppresssor genes at 6p25 and 6p21.3 in cervical carcinoma: occurrence of allelic deletions in precancerous lesions Cancer Res. 61 2001 2119 2123
8. S.W. Wyatt, M. Lancaster, D. Bottorff, and F. Ross History of tobacco use among Kentucky women diagnosed with invasive cervical cancer J. Ky. Med. Assoc. 99 2001 537 539
9. V. Moreno, F.X. Bosch, N. Munoz, C.J. Meijer, K.V. Shah, J.M. Walboomers International Agency for Research on Cancer Multicentric Cervical Cancer Study Group Effects of oral contraceptives on risk of cervical cancer in women with papillomavirus infection: the IARC multicentric case-control study Lancet 30 2002 1085 1092
10. F.X. Bosch, A. Lorincz, N. Munoz, C.J. Meijer, and K.V. Shah The causal relation between human papillomavirus and cervical cancer J. Clin. Pathol. 55 2002 244 265
11. S. DeSanjose, N. Munoz, F.X. Bosch, K. Reimann, N.S. Pedersen, and J. Orfila Sexually transmitted agents and cervical neoplasia in Colombia and Spain Int. J. Cancer 56 1994 358 363
12. T. Anttila, P. Saikku, P. Koskela, A. Bloigu, J. Dillner, and I. Ikaheimo Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma JAMA 285 2001 47 51
13. J.S. Smith, N. Munoz, R. Herrero, J. Eluf-Neto, C. Ngelangel, and S. Franceschi Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the Philippines J. Infect. Dis. 185 2002 324 331
14. R.C. Brunham, I.W. McLean, B. Binns, and R. Peeling Chlamydia trachomatis: its role in tubal infertility J. Infect. Dis. 152 1985 1275 1282
15. J. TerMeulen, X. Yu, H.N. Mgaya, J. Chang-Claude, H. Naher, and G. Meinhard Prevalence of transformation zone Chlamydia trachomatis DNA and serum antibodies in Tanzanian gynaecological in-patients J. Trop. Med. Hyg. 98 1995 89 94
16. R.T. Hodinka, C.H. Davis, J. Choong, and P.B. Wyrick Ultrastructural study of endocytosis of Chlamydia trachomatis by McCoy cells Infect. Immun. 56 1988 1456 1463
17. K.A. Fields, D.J. Mead, C.A. Dooley, and T. Hackstadt Chlamydia trachomatis type III secretion: evidence for a functional apparatus during early-cycle development Mol. Microbiol. 48 2003 671 683
18. M.A. Scidmore, and T. Hackstadt Mammalian 14-3-3beta associates with the Chlamydia trachomatis inclusion membrane via its interaction with IncG Mol. Microbiol. 39 2001 1638 1650
19. D.D. Rockey, D. Grosenbach, D.E. Hruby, M.G. Peacock, R.A. Heinzen, and T. Hackstadt Chlamydia psittaci IncA is phosphorylated by the host cell and is exposed on the cytoplasmic face of the developing inclusion Mol. Microbiol. 24 1997 217 228
20. S.P. Fling, R.A. Sutherland, L.N. Steele, B. Hess, S.E. D'Orazio, and J. Maisonneuve CD8+ T cells recognize an inclusion membrane-associated protein from the vacuolar pathogen Chlamydia trachomatis Proc. Natl. Acad. Sci. U. S. A. 98 2001 1160 1165
21. L. Gail, U. Gross, and W. Bohne Transcriptional profile of Toxoplasma gondii-infected human fibroblasts as revealed by gene-array hybridization Mol. Genet. Genomics 265 2001 905 912
22. G.I. Byrne, and D.A. Krueger Lymphokine-mediated inhibition of Chlamydia replication in mouse fibroblasts is neutralized by anti-gamma interferon immunoglobulin Infect. Immun. 42 1983 1152 1158
23. E. Nettelnbreker, H. Zeidler, H. Bartels, U. Dreses-Werringloer, W. Daeubener, and L. Altmann Koehler Bodies of persistent infection by Chlamydia trachomatis serovar K in TPA-differentiated U937 cells and the role of IFNγ J. Med. Microbiol. 47 1998 141 149
24. W.L. Beatty, G.I. Byrne, and R.P. Morrison Morphologic and antigenic characterization of interferon γ-mediated persistent Chlamydia trachomatis infection in vitro Proc. Natl. Acad. Sci. U. S. A. 90 1993 3998 4002
25. D. Dean, and V.C. Powers Persistent Chlamydia trachomatis infection resist apoptotic stimuli Infect. Immun. 69 2001 2442 2447
26. M.B. Eisen, and P. Brown DNA arrays for analysis of gene expression Methods Enzymol. 1999 30179 30205
27. P. Hegde, R. Qi, K. Abernathy, C. Gay, S. Dharap, and R. Gaspard A concise guide to cDNA microarray analysis Biotechniques 29 2000 548 562
28. Y.H. Yang, S. Dudoit, P. Luu, D.M. Lin, V. Peng, and J. Ngai Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation Nucleic Acids Res. 30 2002 15
29. M.K. Kerr, and G.A. Churchill Experimental design for gene expression microarrays Biostatistics 2 2001 183 201
30. Y. Banjamini, and Y. Hochberg Controlling the false discovery rate: a practical and powerful approach to multiple testing J. R. Stat. Soc. 57 1995 289 300
31. D.L. Wheeler, D.M. Church, A.E. Lash, D.D. Leipe, T.L. Madden, and J.U. Pontius Database resources of the National Center for Biotechnology Information: 2002 update Nucleic Acids Res. 20 2002 13 16
32. F. Coutlee, E. Hankins, and N. Lapointe Comparison between vaginal tampon and cervicovaginal lavage specimen collection for detection of human papillomavirus DNA by the polymerase chain reaction J. Virol. 5 1997 42 47
33. M. Lovett, C.C. Kuo, K. Holmes, and S. Falkow Plasmids in the genus Chlamydia J.D. Nelson C. Grassi Current Chemotherapy and Infectious Diseases: Proceedings of the 11th International Congress of Chemotherapy and 19th Interscience Conference on Antibiotic Agents and Chemotherapy 1980 American Society for Microbiology Washington (DC)
34. M. Comanducci, S. Ricci, R. Cevenini, and G. Ratti Diversity of the Chlamydial common plasmid in biovars with different pathogenicity Plasmid 23 1990 149 154
35. C. Aoyama, J. Peters, S. Senadheera, P. Liu, and H. Shimada Uterine cervical dysplasia and cancer: identification of c-myc status by quantitative polymerase chain reaction Diagn. Mol. Pathol. 7 1998 324 330
36. R.R. Finan, H. Tanim, and W.Y. Almawi Identification of Chlamydia trachomatis DNA in human papillomavirus (HPV) positive women with normal and abnormal cytology Arch. Gynecol. Obstet. 266 2002 168 171
37. L.E. Lindner, S. Geerling, J.A. Nettum, S.L. Miller, K.H. Altman, and S.R. Wechter Identification of Chlamydia trachomatis in cervical smears by immuno-fluorescence: technic, sensitivity and specificity Am. J. Clin. Pathol. 85 1986 180 185
38. J. Paavonen, and E. Purola Cytologic findings in cervical chlamydial infection Med. Biol. 58 1980 174 178
39. S. Geerling, J.A. Nettum, L.E. Lindner, S.L. Miller, L. Dutton, and S. Wechter Sensitivity and specificity of the Papanicolaou-stained cervical smear in the diagnosis of Chlamydia trachomatis infection Acta Cytol. 29 1985 671 675
40. B.J. Thomas, R.T. Evans, D.A. Hawkins, and D. Taylor-Robinson Sensitivity of detecting Chlamydia trachomatis elementary bodies in smears by fluorescent labelled monoclonal antibody: comparison with conventional Chlamydial isolation J. Clin. Pathol. 37 1984 812 816
41. A.B. Harnekar, G. Leiman, and S. Markowitz Cytologically detected Chlamydial changes and progression of cervical intraepithelial neoplasias Acta Cytol. 29 1985 661 664
42. B.K. Knight, An investigation of criteria for the morphologic diagnosis of infection by Chlamydia trachomatis in the uterine cervix. PhD thesis, in the University of Cape Town, 2004; 113-116, and 126-128.
43. T. Schlott, G. Ruda, M. Hoppert, H. Nagel, S. Reimer, and I.K. Schumacher-Lütge The in situ polymerase chain reaction for detection of Chlamydia trachomatis J. Histochem. Cytochem. 46 1998 1017 1023
44. J.G. Kuipers, H. Zeidler, and L. Kohler How does Chlamydia cause arthritis? Rheum. Dis. Clin. North Am. 29 2003 613 629
45. A.M. Beutler, J.A. Whittum-Hudson, R. Nanagara, H.R. Schumacher, and A.P. Hudson Intracellular location of inapparently infecting Chlamydia in synovial tissue from patients with Reiter's syndrome Immunol. Res. 13 1994 163 171
46. S. Hess, C. Rheinheimer, F. Tidow, G. Bartling, C. Kaps, J. Lauber, and J. Buer The reprogrammed host: Chlamydia trachomatis-induced up-regulation of glycoprotein 130 cytokines, transcription factors, and antiapoptotic genes Arthritis Rheum. 44 2001 2392 2401
47. M. Xia, R.E. Bumgarner, M.F. Lampe, and W.E. Stamm Chlamydia trachomatis infection alters host cell transcription in diverse cellular pathways J. Infect. Dis. 187 2003 424 434
48. S.S. Fakharzadeh, S.P. Trusko, and D.L. George Tumorigenic potential associated with enhanced expression of a gene that is amplified in mouse tumor cell line EMBO J. 10 1991 1565 1569
49. L.M. De la Maza, E.M. Peterson, L.E. Burton, P.W. Gray, E. Rinderknecht, and C.W. Czarniecki The antichlamydial, antiviral, and antiproliferative activities of human gamma interferon are dependent on the integrity of the C terminus of the interferon molecule Infect. Immun. 55 1987 2727 2733
50. H. Ogawa, K. Fukushima, I. Sasaki, and S. Matsuno Identification of genes involved in mucosal defense and inflammation associated with normal enteric bacteria Am. J. Physiol.: Gastrointest. Liver Physiol. 279 2000 G492 G499
51. H. Wilkman, E. Kettunen, J.K. Seppanen, A. Karjalainen, J. Hollmen, and S. Anttila Identification of differentially expressed genes in pulmonary adenocarcinoma by using cDNAmicroarray Oncogene 21 2002 5804 5813
52. L.C. Norkin, S.A. Wolfrom, and E.S. Stuart Association of caveolin with Chlamydia trachomatis inclusions at early and late stages of infection Exp. Cell Res. 266 2001 229 238
53. P.E. Scherer, R.Y. Lewis, D. Volonte, J.A. Engelman, F. Galbiati, and J. Couet Cell-type and tissue-specific expression of caveolin-2. Caveolins 1 and 2 co-localize and form a stable hetero-oligomeric complex in vivo J. Biol. Chem. 272 1997 29337 29346
54. J. Couet, M. Sargiacomo, and M.P. Lisanti Interaction of a receptor tyrosine kinase, EGF-R, with caveolins. Caveolin binding negatively regulates tyrosine and serine/threonine kinase activities J. Biol. Chem. 272 1997 30429 30438
55. F. Bender, M. Montoya, V. Monardes, L. Leyton, and A.F. Quest Caveolae and caveolae-like membrane domains in cellular signalling and disease: identification of downstream targets for the tumor suppressor protein caveolin-1 Biol. Res. 35 2002 151 167
56. B. Zhang, J.W. Shih, D.J. Wear, S. Tsai, and S.C. Lo High-level expression of H-ras and c-myc oncogenes in mycoplasma-mediated malignant cell transformation Proc. Soc. Exp. Biol. Med. 214 1997 359 366
57. S. Tsuji, M. Tsujii, W.H. Sun, E.S. Gunawan, H. Murata, and S. Kawano Helicobacter pylori and gastric carcinogenesis J. Clin. Gastroenterol. 25 1997 S186 S197
58. N.H. Cho, Y.T. Kim, and J.W. Kim Correlation between G1 cyclins and HPV in the uterine cervix Int. J. Gynecol. Pathol. 16 1997 339 347
59. E. Felley-Bosco, F. Bender, and A.F. Quest Caveolin-1-mediated post-transcriptional regulation of inducible nitric oxide synthase in human colon carcinoma cells Biol. Res. 35 2002 169 176
60. J. Mayer, M.L. Woods, Z. Vavrin, and J.B. Hibbs Jr. Gamma interferon-induced nitric oxide production reduces Chlamydia trachomatis infectivity in McCoy cells Infect. Immun. 61 1993 491 497
61. J.U. Igietseme, I.M. Uriri, M. Chow, E. Abe, and R.G. Rank Inhibition of intracellular multiplication of human strains of Chlamydia trachomatis by nitric oxide Biochem. Biophys. Res. Commun. 232 1997 595 601
62. C. Wahl, S. Maier, R. Marre, and A. Essig Chlamydia pneumoniae induces the expression of inhibitor of apoptosis 2 (c-IAP2) in a human monocytic cell line by an NF-kappaB-dependent pathway Int. J. Med. Microbiol. 293 2003 377 381
63. Q. Tian, J. Taupin, S. Elledge, M. Robertson, and P. Anderson Fas-activated serine/threonine kinase (FAST) phosphorylates TIA-1 during Fas-mediated apoptosis J. Exp. Med. 182 1995 865 874
64. G. Zhong, T. Fan, and L. Liu Chlamydia inhibits interferon gamma-inducible major histocompatibility complex class II expression by degradation of upstream stimulatory factor 1 J. Exp. Med. 189 1999 1931 1938
65. G. Zhong, L. Liu, T. Fan, P. Fan, and H. Ji Degradation of transcription factor RFX5 during the inhibition of both constitutive and interferon gamma-inducible major histocompatibility complex class I expression in Chlamydia-infected cells J. Exp. Med. 191 2000 1525 1534
66. B. Razani, Y. Altschuler, L. Zhu, R.G. Pestell, K.E. Mostov, and M.P. Lisanti Caveolin-1 expression is down-regulated in cells transformed by the human papilloma virus in a p53-dependent manner. Replacement of caveolin-1 expression suppresses HPV-mediated cell transformation Biochemistry 39 2000 13916 13924
67. A.E. Al Moustafa, W.D. Foulkes, N. Benlimame, A. Wong, L. Yen, and J. Bergeron E6/E7 proteins of HPV type 16 and ErbB-2 cooperate to induce neoplastic transformation of primary normal oral epithelial cells Oncogene 23 2004 350 358